Renishaw Share Discussion Threads

[chrisgail] 17/10/2013 10:06

Profits in first quarter down more than 50%.

[redartbmud] 16/10/2013 12:42

Not long to wait. I for one will be at the AGM.

[chrisgail] 16/10/2013 10:48

The market doesn't seem to be looking forward with any optimism to tomorrows IMS.

[chairman20] 03/9/2013 19:48

suspiciously like they are trying to do some PR?!!!

having taken a Monkish vow of silence against flacks, hacks,
and analysts.

[robinnicolson] 03/9/2013 14:17

When Renishaw tweet a link to a BBC News story: "UK manufacturing 'booming again'", are management subtly hinting that our business is doing just fine at the moment?

[deadly] 09/8/2013 11:20

Strong all of a sudden. Love this volatility for trading.

[redartbmud] 25/7/2013 07:43

Normal service resumed. Sold out too early, but achieved the object of increasing my weighting at minimal cost, so can't grumble too much.

[apad] 25/7/2013 05:45

One of the directors told me a few of years ago that they didn't much talk to the Tintins, so I suspect this is simply formalising the status quo.
Didn't like the eps one little bit - my expectation was 105 to 109 not less than last year.
apad

[redartbmud] 24/7/2013 20:57

Chair

Thanks for the heads up on the webcast. I will listen in tomorrow, when it is linked to the web-site.
They wheeled out good old Ben then - Renishaw's Kermit the Frog/Bill Gates soundalike. He can talk the hind legs of a donkey.


red

[chairman20] 24/7/2013 18:54

I love 'spivs'

they will punish the Board and management
no doubt

did anyone listen in to the questions on the webcast today?

[dasv] 24/7/2013 18:01

whitestone - yes I can completely imagine that this is the case. They want to concentrate on running their business, not sucking-up to analysts, or duping PI's. It's actually a good thing - I was just second guessing how the spivs themselves would react.

1500 support held - a good sign.

[whitestone] 24/7/2013 16:22

dasv

Not a lack of investor meetings but rather a desire to place all investors and indeed potential investors on the same basis. They obviously intend to make clear they will not give private briefings to a select few to profit therefrom. These people are Engineers and have little or no time for the City spivs perhaps..!

[dasv] 24/7/2013 15:50

thanks for info red.

chairman I think you make valid points - I should clarify I sold at open having bought higher.

The expansion of capacity coupled with revenue growth increases is encouraging however the lack of investor meetings is going to annoy the city. This could affect the rating (PE). For me this is one to keep an eye on and buy back on positive updates.

[redartbmud] 24/7/2013 15:24

Chairman

From Investegate

15 July Montaro 2.99% - down from just over 3%
31 Jan Baillie Gifford 5.29%
16 Jan Blackrock 4.015 - reduced

Looks like the only movements since the AGM

Can't see Old Mutual with declarable interest.

red

[chairman20] 24/7/2013 12:44

thanks redart
v helpful

no old mutual med size com-pany fund?

[redartbmud] 24/7/2013 12:42

I took today's stake off the table at £15.264, leaving the gain in shares in my SIPP. Reduced the average price of the portfolio and increased the yield as a result. This is win win for me, as I now have the cash available again, and will get future dividends for free.
Most of my holding is at negligible cost, derived from a certain amount of trading.
As I am in drawdown, I have to watch the pennies carefully.


red

[redartbmud] 24/7/2013 10:27

Chairman

I agree on succession/risk, but if/when McMurtry (Age 72) or Deer (Age 74) shuffle off this mortal coil, we could see a bid.

McMurtry will not let healthcare go lightly, if at all, but it doesn't look to me like a long term contributor, so it is a negative.

Bill Whitely as a non-exec is a big plus. I rate him very highly. I would have liked to see him as Chair. I would expect wise counsel from him.
The company could benefit from a bit more shake up of the board.

£21m of cash at the year end

Y/e
Blackrock 5.07%
Capital Research 4.76%
Standard life 4.99%
I have not checked on any changes.

red

[a3477681] 24/7/2013 09:51

The couple of analysts Investec (Under Review) and Numis (Hold) do not encourage me to buy back in yet. Investec "missed guidance by 5 M operating margins less than FY12 and H1 13 and for a company often hard to read no one to one meetings unhelpful. They want to assess the balance between revenue and growth potential.

It is a great company and product range and I like its ethos but my feeling is that it was over bought which is why I sold at 16.95 (too early then as it happened)I hope to buy lower but good luck to those that want to hold and I am probably wrong.

[chairman20] 24/7/2013 09:35

dasv -1st timer issues/questions

The abandonment of investor meetings coupled with the obvious (and
no doubt irritating) questions about succession risk and succession
planning - is hardly a support for the share price.

Costs rising twice as fast as revenues don't help but the explanation
in the Miskin expansion and aquisition-led 10% increase in headcount
is pretty obvious.

Then there I the still-to be proven (in profit terms) diversification into
healthcare engineering.

Not surprising there should be weakness perhaps. Do you agree?

Not been able to find out anything about insti holders - do you have
any info of funds (perhaps FTSE350) as long-term holders?

Many Thanks and apologies for the (obviously ignorant) questions

[redartbmud] 24/7/2013 09:18

dasv/Chair

Thanks for the comments.

red

[chairman20] 24/7/2013 09:14

dasv

not a chartist myself but isn't the support line now 1450 (top of previous resistance?)

and the question is if it breaches that is there any technical reson why it should not see 12500 ish again in the near future? Just asking

directed here by your comments.

thanks

[dasv] 24/7/2013 09:06

1500 support needs to hold till close to prevent further technical damage.

[redartbmud] 24/7/2013 08:53

bw

Thanks for the comment.

I just feel that there is a loyal following for the company. Trading volumes are tight and any movement tends to be exaggerated.
The top line is up, which is a positive, and the company is still in the early stages of the Miskin development.
I like the idea of new products, and the company is a world leader in it's field.


I must confess however that I did not run the slide rule over my any calculations and have gone with my gut rather than any more structured approach.
He who dares Rodney.....

red

[broadwood] 24/7/2013 07:58

red - not really. I just thought there might be a few weeks/months of weakness whilst this news beds in. But I still like them and probably will get back in down the road.

Best of luck.

[redartbmud] 24/7/2013 07:55

Added at 8.43. Long term investment.

Divergence of opinion then bw.

red